Receive a complete Daily History of this Stock You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file in ASCII format within a few hours or ordering. Product Details | Order

Business Description
Chiron Corporation is a global pharmaceutical company that is focused on developing products for cancer and infectious disease. The Company continues to build upon its cancer franchise, which has three dimensions, including immune system modulators, monoclonal antibodies and novel anti-cancer agents. In the infectious disease area, the Company has a range of products. The Company commercializes its products through three business units, which include biopharmaceuticals, vaccines and blood testing. Chiron Biopharmaceuticals discovers, develops, manufactures and markets a range of therapeutic products. Chiron Vaccines offers more than 30 vaccines for adults and children. Chiron Blood Testing provides products used by the blood banking industry.

Financial Information
CHIR is a biotechnology company that is developing products for preventing and treating cancer, infectious diseases and cardiovascular disease. For the six months ended 6/30/02, revenues rose 6% to $551.5 million. Net income from continuing operations fell 60% to $31.5 million. Revenues reflect increased biopharmaceuticals sales. Lower net income reflects a $54.8 million write-off of purchased in-process technologies.